Simplex Trading
SPRY icon

Simplex Trading’s ARS Pharmaceuticals SPRY Stock Holding History

Simplex Trading’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.8K Buy
+4,218
New +$36.3K ﹤0.01% 6659
2025
Q2 		– Sell
-44,092
Closed -$636K – 9678
2025
Q1 		$554K Buy
44,092
+31,786
+258% +$382K ﹤0.01% 3303
2024
Q4 		$129K Sell
12,306
-43,309
-78% -$607K ﹤0.01% 4944
2024
Q3 		$806K Buy
+55,615
New +$661K ﹤0.01% 3120
2024
Q1 		– Sell
-68,157
Closed -$508K – 9829
2023
Q4 		$373K Buy
68,157
+42,006
+161% +$184K ﹤0.01% 4003
2023
Q3 		$98K Buy
+26,151
New +$172K ﹤0.01% 5106
2022
Q3 		– Sell
-39,195
Closed -$193K – 10829
2022
Q2 		$166K Buy
39,195
+38,824
+10,465% +$135K ﹤0.01% 4860
2022
Q1 		$1K Sell
371
-1,776
-83% -$7.73K ﹤0.01% 10147
2021
Q4 		$14K Buy
+2,147
New +$17.4K ﹤0.01% 8762

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tyro Capital Management Miami, Florida $446M AUM 84.15% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Simplex Trading's SPRY Position: Q2 2026 in Review

Simplex Trading opened a new position in ARS Pharmaceuticals (SPRY) in Q2 2026: 4,218 shares worth $33.8K. The stake represents ﹤0.01% of the portfolio and ranks #6659 among its holdings. This is a return to the name: Simplex Trading previously reported a position in SPRY as recently as Q1 2025.

Simplex Trading first reported a position in SPRY in Q4 2021 and has held it in 9 quarters since. The position peaked at $806K in Q3 2024. 209 funds tracked by Wall St. Rank hold SPRY as of Q2 2026.

  • Simplex Trading held 4,218 shares of ARS Pharmaceuticals worth $33.8K as of Q2 2026.
  • ARS Pharmaceuticals was a new Simplex Trading position in Q2 2026.
  • ARS Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #6659 holding.
  • Simplex Trading first reported a position in ARS Pharmaceuticals in Q4 2021 and has held it in 9 quarters since.
  • Simplex Trading's ARS Pharmaceuticals position peaked at $806K in Q3 2024.
  • 209 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.